Report
EUR 12.77 For Business Accounts Only

MANI sees a downgrade to Slightly Negative on account of less fundamental stars

The independent financial analyst theScreener just lowered the general evaluation of MANI (JP), active in the Medical Equipment industry. As regards its fundamental valuation, the title now shows 1 out of 4 stars while market behaviour can be considered moderately risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Slightly Negative. As of the analysis date February 22, 2022, the closing price was JPY 1,561.00 and its target price was estimated at JPY 1,396.43.
Underlying
Mani

MANI is mainly engaged in the manufacture and sale of medical equipment. Along with its subsidiaries, Co. operates in three business segments: surgical-related, eyeless needle-related, and dental-related. Co.'s principal products are surgical suture needles and threads, as well as ophthalmic knives, born saws, blood vessel knives and other surgical equipment; eyeless surgical suture needles; and dental root canal treatment equipment, such as reamers, files and broaches; grinding and abrasive agents, such as carborundum points, and silicone points; and rotating dental treatment equipment, such as dia-burs and carbide burs, as well as dental materials and dental stereomicroscope.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch